Merck to begin Phase 3 trials for investigational once monthly HIV prevention pill Ruchika Sharma15 July 2025 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of the EXPrESSIVE Phase 3 clinical trials,...
Merck Animal Health gets USFDA nod for Bravecto Quantum to protect dogs from fleas, ticks Ruchika Sharma13 July 2025 1:45 PM ISTRahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway,...
Merck application for two drug regimen for adults with virologically suppressed HIV 1 infection under USFDA review Ruchika Sharma11 July 2025 12:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...
Merck to buy Verona Pharma for USD 10 billion Ruchika Sharma10 July 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Verona Pharma plc, a biopharmaceutical company focused on...
Merck in talks to acquire respiratory drugmaker Verona Pharma: Report Ruchika Sharma9 July 2025 4:00 PM ISTBengaluru: Merck is reportedly in talks to acquire lung disease-focused biotech Verona Pharma in a deal worth nearly USD 10 billion, the Financial...
USFDA grants priority review for Winrevair label update based on ZENITH Trial: Merck Ruchika Sharma5 July 2025 2:39 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...
Merck Enflonsia wins ACIP backing for RSV protection in infants under 8 months Ruchika Sharma29 Jun 2025 1:15 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Centers for Disease Control and Prevention (CDC)...
Enlicitide Decanoate Promising as Oral PCSK9 Inhibitor in Hyperlipidemia in Phase 3 trials Dr. Prem Aggarwal21 Jun 2025 7:30 AM ISTPhase 3 trials have demonstrated that enlicitide decanoate significantly reduces LDL cholesterol, showing strong potential as an oral PCSK9 inhibitor...
FDA Approves Clesrovimab to Prevent RSV in Infants Dr. Kamal Kant Kohli20 Jun 2025 9:00 PM ISTThe FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in neonates and infants during...
Phase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant Prostate Cancer: Merck, Daiichi Sankyo Ruchika Sharma19 Jun 2025 10:00 AM ISTBasking Ridge: Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating...
Merck Keytruda approved by USFDA for Advanced Head and Neck Cancer Ruchika Sharma15 Jun 2025 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Merck begins Phase 3 study for Dengue vaccine candidate Ruchika Sharma13 Jun 2025 11:00 AM ISTMerck is establishing a program of clinical trials for V181, including conducting trials globally, in places where dengue is a significant health...
